Milestone Pharmaceuticals Inc. · NASDAQ:MIST
Trails Edge Capital Partners, LP's stake in Milestone Pharmaceuticals Inc. fell to 4.30% (Schedule 13G/A)
Event Mar 20, 2026 · Filed Mar 26, 2026
Trails Edge Capital Partners, LP's stake in Milestone Pharmaceuticals Inc. fell to 4.30%, 5,333,333 shares, as a passive investor on Mar 20, 2026. Filed Mar 26, 2026 (Schedule 13G/A).
- Stake
- 4.30%
- Shares
- 5,333,333
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 4.30% | 5,333,333 |
| Trails Edge Biotechnology Master Fund, LP | 4.30% | 5,333,333 |
| Ortav Yehudai | 4.30% | 5,333,333 |
Source
Related
- Milestone Pharmaceuticals Inc.
- Trails Edge Capital Partners, LP
- Milestone Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Trails Edge Capital Partners, LP · Nov 14, 2025
- Schedule 13G · Trails Edge Capital Partners, LP · Jul 21, 2025
- Schedule 13G · Pavaki Capital Management LLC · Aug 7, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Form 4 · Oliveto Joseph · Apr 20, 2026
- Schedule 13G · Propel Bio Management, LLC · Dec 23, 2025